HEADER HYDROLASE/HYDROLASE INHIBITOR 26-FEB-20 6M1K TITLE USP7 IN COMPLEX WITH A NOVEL INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 7; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: DEUBIQUITINATING ENZYME 7,HERPESVIRUS-ASSOCIATED UBIQUITIN- COMPND 5 SPECIFIC PROTEASE,UBIQUITIN THIOESTERASE 7,UBIQUITIN-SPECIFIC- COMPND 6 PROCESSING PROTEASE 7; COMPND 7 EC: 3.4.19.12; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: USP7, HAUSP; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR, COMPLEX, USP7, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.J.LIU,X.Y.ZHOU,M.L.LI,H.B.SUN,X.A.WEN REVDAT 2 29-NOV-23 6M1K 1 REMARK REVDAT 1 10-MAR-21 6M1K 0 JRNL AUTH M.LI,S.LIU,H.CHEN,X.ZHOU,J.ZHOU,S.ZHOU,H.YUAN,Q.L.XU,J.LIU, JRNL AUTH 2 K.CHENG,H.SUN,Y.WANG,C.CHEN,X.WEN JRNL TITL N-BENZYLPIPERIDINOL DERIVATIVES AS NOVEL USP7 INHIBITORS: JRNL TITL 2 STRUCTURE-ACTIVITY RELATIONSHIPS AND X-RAY CRYSTALLOGRAPHIC JRNL TITL 3 STUDIES. JRNL REF EUR.J.MED.CHEM. V. 199 12279 2020 JRNL REFN ISSN 0223-5234 JRNL PMID 32497973 JRNL DOI 10.1016/J.EJMECH.2020.112279 REMARK 2 REMARK 2 RESOLUTION. 2.26 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.14_3246 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.26 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.18 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.8 REMARK 3 NUMBER OF REFLECTIONS : 35489 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.235 REMARK 3 R VALUE (WORKING SET) : 0.233 REMARK 3 FREE R VALUE : 0.269 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.480 REMARK 3 FREE R VALUE TEST SET COUNT : 1944 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 41.1800 - 5.4320 0.99 2572 149 0.1769 0.2095 REMARK 3 2 5.4320 - 4.3130 0.96 2467 137 0.1731 0.1839 REMARK 3 3 4.3130 - 3.7683 0.96 2445 146 0.1995 0.2148 REMARK 3 4 3.7683 - 3.4239 0.97 2445 142 0.2161 0.2392 REMARK 3 5 3.4239 - 3.1786 0.95 2416 139 0.2570 0.3354 REMARK 3 6 3.1786 - 2.9913 0.93 2339 138 0.2878 0.3429 REMARK 3 7 2.9913 - 2.8415 0.91 2279 134 0.3296 0.4017 REMARK 3 8 2.8415 - 2.7178 0.93 2342 134 0.3158 0.3305 REMARK 3 9 2.7178 - 2.6132 0.95 2397 137 0.3017 0.4027 REMARK 3 10 2.6132 - 2.5231 0.95 2391 138 0.3135 0.3475 REMARK 3 11 2.5231 - 2.4442 0.95 2367 139 0.3216 0.4071 REMARK 3 12 2.4442 - 2.3743 0.95 2392 140 0.3223 0.3797 REMARK 3 13 2.3743 - 2.3118 0.96 2398 137 0.3251 0.3794 REMARK 3 14 2.3118 - 2.2554 0.91 2295 134 0.3160 0.3748 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.350 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 33.900 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 52.99 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6M1K COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 27-FEB-20. REMARK 100 THE DEPOSITION ID IS D_1300015893. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-NOV-19 REMARK 200 TEMPERATURE (KELVIN) : 273 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : CU FINE FOCUS REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 200K REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35627 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.255 REMARK 200 RESOLUTION RANGE LOW (A) : 41.180 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.1 REMARK 200 DATA REDUNDANCY : 6.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 21.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.26 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.34 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.07500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5N9T REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.65 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.49 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRIS (HYDROXYMETHYL)AMINOMETHANE REMARK 280 HYDROCHLORIDE, PH 7.0, 20% (V/V) PEG 1000, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 34.60000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 208 REMARK 465 ASP A 502 REMARK 465 ASP A 503 REMARK 465 ASP A 504 REMARK 465 LEU A 505 REMARK 465 SER A 506 REMARK 465 VAL A 507 REMARK 465 ARG A 508 REMARK 465 LYS A 554 REMARK 465 LYS B 208 REMARK 465 LYS B 209 REMARK 465 HIS B 210 REMARK 465 ASP B 502 REMARK 465 ASP B 503 REMARK 465 ASP B 504 REMARK 465 LEU B 505 REMARK 465 SER B 506 REMARK 465 VAL B 507 REMARK 465 ARG B 508 REMARK 465 GLN B 553 REMARK 465 LYS B 554 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 209 CG CD CE NZ REMARK 470 HIS A 210 CG ND1 CD2 CE1 NE2 REMARK 470 ARG B 340 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 388 CG CD OE1 OE2 REMARK 470 LYS B 391 CG CD CE NZ REMARK 470 LYS B 394 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ALA B 381 CB - CA - C ANGL. DEV. = -14.6 DEGREES REMARK 500 ALA B 381 N - CA - C ANGL. DEV. = -17.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 223 -130.94 45.92 REMARK 500 TYR A 224 -3.21 -59.26 REMARK 500 ALA A 381 30.13 -97.87 REMARK 500 ASP A 416 -123.35 59.39 REMARK 500 GLN A 417 -76.55 -75.76 REMARK 500 ASP A 444 84.59 -158.89 REMARK 500 ASP A 482 -120.32 58.66 REMARK 500 ILE A 494 -86.64 -107.25 REMARK 500 CYS B 223 -119.34 57.20 REMARK 500 TRP B 285 79.72 -104.21 REMARK 500 GLU B 383 -56.94 -122.32 REMARK 500 HIS B 384 -0.31 -52.78 REMARK 500 THR B 415 -149.28 -115.04 REMARK 500 ASP B 416 47.72 -147.30 REMARK 500 ASP B 482 -124.90 54.58 REMARK 500 ILE B 494 -81.34 -100.24 REMARK 500 CYS B 510 36.94 -82.77 REMARK 500 LEU B 528 30.40 -99.76 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EZF A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EZF B 601 DBREF 6M1K A 208 554 UNP Q93009 UBP7_HUMAN 208 554 DBREF 6M1K B 208 554 UNP Q93009 UBP7_HUMAN 208 554 SEQRES 1 A 347 LYS LYS HIS THR GLY TYR VAL GLY LEU LYS ASN GLN GLY SEQRES 2 A 347 ALA THR CYS TYR MET ASN SER LEU LEU GLN THR LEU PHE SEQRES 3 A 347 PHE THR ASN GLN LEU ARG LYS ALA VAL TYR MET MET PRO SEQRES 4 A 347 THR GLU GLY ASP ASP SER SER LYS SER VAL PRO LEU ALA SEQRES 5 A 347 LEU GLN ARG VAL PHE TYR GLU LEU GLN HIS SER ASP LYS SEQRES 6 A 347 PRO VAL GLY THR LYS LYS LEU THR LYS SER PHE GLY TRP SEQRES 7 A 347 GLU THR LEU ASP SER PHE MET GLN HIS ASP VAL GLN GLU SEQRES 8 A 347 LEU CYS ARG VAL LEU LEU ASP ASN VAL GLU ASN LYS MET SEQRES 9 A 347 LYS GLY THR CYS VAL GLU GLY THR ILE PRO LYS LEU PHE SEQRES 10 A 347 ARG GLY LYS MET VAL SER TYR ILE GLN CYS LYS GLU VAL SEQRES 11 A 347 ASP TYR ARG SER ASP ARG ARG GLU ASP TYR TYR ASP ILE SEQRES 12 A 347 GLN LEU SER ILE LYS GLY LYS LYS ASN ILE PHE GLU SER SEQRES 13 A 347 PHE VAL ASP TYR VAL ALA VAL GLU GLN LEU ASP GLY ASP SEQRES 14 A 347 ASN LYS TYR ASP ALA GLY GLU HIS GLY LEU GLN GLU ALA SEQRES 15 A 347 GLU LYS GLY VAL LYS PHE LEU THR LEU PRO PRO VAL LEU SEQRES 16 A 347 HIS LEU GLN LEU MET ARG PHE MET TYR ASP PRO GLN THR SEQRES 17 A 347 ASP GLN ASN ILE LYS ILE ASN ASP ARG PHE GLU PHE PRO SEQRES 18 A 347 GLU GLN LEU PRO LEU ASP GLU PHE LEU GLN LYS THR ASP SEQRES 19 A 347 PRO LYS ASP PRO ALA ASN TYR ILE LEU HIS ALA VAL LEU SEQRES 20 A 347 VAL HIS SER GLY ASP ASN HIS GLY GLY HIS TYR VAL VAL SEQRES 21 A 347 TYR LEU ASN PRO LYS GLY ASP GLY LYS TRP CYS LYS PHE SEQRES 22 A 347 ASP ASP ASP VAL VAL SER ARG CYS THR LYS GLU GLU ALA SEQRES 23 A 347 ILE GLU HIS ASN TYR GLY GLY HIS ASP ASP ASP LEU SER SEQRES 24 A 347 VAL ARG HIS CYS THR ASN ALA TYR MET LEU VAL TYR ILE SEQRES 25 A 347 ARG GLU SER LYS LEU SER GLU VAL LEU GLN ALA VAL THR SEQRES 26 A 347 ASP HIS ASP ILE PRO GLN GLN LEU VAL GLU ARG LEU GLN SEQRES 27 A 347 GLU GLU LYS ARG ILE GLU ALA GLN LYS SEQRES 1 B 347 LYS LYS HIS THR GLY TYR VAL GLY LEU LYS ASN GLN GLY SEQRES 2 B 347 ALA THR CYS TYR MET ASN SER LEU LEU GLN THR LEU PHE SEQRES 3 B 347 PHE THR ASN GLN LEU ARG LYS ALA VAL TYR MET MET PRO SEQRES 4 B 347 THR GLU GLY ASP ASP SER SER LYS SER VAL PRO LEU ALA SEQRES 5 B 347 LEU GLN ARG VAL PHE TYR GLU LEU GLN HIS SER ASP LYS SEQRES 6 B 347 PRO VAL GLY THR LYS LYS LEU THR LYS SER PHE GLY TRP SEQRES 7 B 347 GLU THR LEU ASP SER PHE MET GLN HIS ASP VAL GLN GLU SEQRES 8 B 347 LEU CYS ARG VAL LEU LEU ASP ASN VAL GLU ASN LYS MET SEQRES 9 B 347 LYS GLY THR CYS VAL GLU GLY THR ILE PRO LYS LEU PHE SEQRES 10 B 347 ARG GLY LYS MET VAL SER TYR ILE GLN CYS LYS GLU VAL SEQRES 11 B 347 ASP TYR ARG SER ASP ARG ARG GLU ASP TYR TYR ASP ILE SEQRES 12 B 347 GLN LEU SER ILE LYS GLY LYS LYS ASN ILE PHE GLU SER SEQRES 13 B 347 PHE VAL ASP TYR VAL ALA VAL GLU GLN LEU ASP GLY ASP SEQRES 14 B 347 ASN LYS TYR ASP ALA GLY GLU HIS GLY LEU GLN GLU ALA SEQRES 15 B 347 GLU LYS GLY VAL LYS PHE LEU THR LEU PRO PRO VAL LEU SEQRES 16 B 347 HIS LEU GLN LEU MET ARG PHE MET TYR ASP PRO GLN THR SEQRES 17 B 347 ASP GLN ASN ILE LYS ILE ASN ASP ARG PHE GLU PHE PRO SEQRES 18 B 347 GLU GLN LEU PRO LEU ASP GLU PHE LEU GLN LYS THR ASP SEQRES 19 B 347 PRO LYS ASP PRO ALA ASN TYR ILE LEU HIS ALA VAL LEU SEQRES 20 B 347 VAL HIS SER GLY ASP ASN HIS GLY GLY HIS TYR VAL VAL SEQRES 21 B 347 TYR LEU ASN PRO LYS GLY ASP GLY LYS TRP CYS LYS PHE SEQRES 22 B 347 ASP ASP ASP VAL VAL SER ARG CYS THR LYS GLU GLU ALA SEQRES 23 B 347 ILE GLU HIS ASN TYR GLY GLY HIS ASP ASP ASP LEU SER SEQRES 24 B 347 VAL ARG HIS CYS THR ASN ALA TYR MET LEU VAL TYR ILE SEQRES 25 B 347 ARG GLU SER LYS LEU SER GLU VAL LEU GLN ALA VAL THR SEQRES 26 B 347 ASP HIS ASP ILE PRO GLN GLN LEU VAL GLU ARG LEU GLN SEQRES 27 B 347 GLU GLU LYS ARG ILE GLU ALA GLN LYS HET EZF A 601 39 HET EZF B 601 39 HETNAM EZF METHYL 4-[[4-[[3-[4-(AMINOMETHYL)PHENYL]-2-METHYL-7- HETNAM 2 EZF OXIDANYLIDENE-PYRAZOLO[4,3-D]PYRIMIDIN-6-YL]METHYL]-4- HETNAM 3 EZF OXIDANYL-PIPERIDIN-1-YL]METHYL]-3-CHLORANYL-BENZOATE FORMUL 3 EZF 2(C28 H31 CL N6 O4) FORMUL 5 HOH *164(H2 O) HELIX 1 AA1 TYR A 224 PHE A 234 1 11 HELIX 2 AA2 THR A 235 MET A 244 1 10 HELIX 3 AA3 SER A 255 SER A 270 1 16 HELIX 4 AA4 THR A 276 PHE A 283 1 8 HELIX 5 AA5 ASP A 295 MET A 311 1 17 HELIX 6 AA6 GLY A 318 ARG A 325 1 8 HELIX 7 AA7 ASN A 359 VAL A 368 1 10 HELIX 8 AA8 ASP A 374 LYS A 378 5 5 HELIX 9 AA9 GLY A 382 HIS A 384 5 3 HELIX 10 AB1 ASP A 412 ASP A 416 5 5 HELIX 11 AB2 ASP A 434 LEU A 437 5 4 HELIX 12 AB3 THR A 489 ILE A 494 1 6 HELIX 13 AB4 GLU A 495 TYR A 498 5 4 HELIX 14 AB5 LYS A 523 LEU A 528 1 6 HELIX 15 AB6 THR A 532 ILE A 536 5 5 HELIX 16 AB7 PRO A 537 GLN A 553 1 17 HELIX 17 AB8 TYR B 224 PHE B 234 1 11 HELIX 18 AB9 THR B 235 MET B 244 1 10 HELIX 19 AC1 SER B 255 SER B 270 1 16 HELIX 20 AC2 THR B 276 PHE B 283 1 8 HELIX 21 AC3 ASP B 295 MET B 311 1 17 HELIX 22 AC4 GLY B 318 ARG B 325 1 8 HELIX 23 AC5 ASN B 359 VAL B 368 1 10 HELIX 24 AC6 ASP B 374 LYS B 378 5 5 HELIX 25 AC7 ASP B 434 LEU B 437 5 4 HELIX 26 AC8 THR B 489 ILE B 494 1 6 HELIX 27 AC9 GLU B 495 TYR B 498 5 4 HELIX 28 AD1 LYS B 523 LEU B 528 1 6 HELIX 29 AD2 THR B 532 ILE B 536 5 5 HELIX 30 AD3 PRO B 537 GLU B 551 1 15 SHEET 1 AA1 4 ARG A 340 TYR A 347 0 SHEET 2 AA1 4 GLY A 326 CYS A 334 -1 N MET A 328 O GLU A 345 SHEET 3 AA1 4 ALA A 389 PHE A 395 -1 O GLU A 390 N GLN A 333 SHEET 4 AA1 4 GLU A 371 LEU A 373 -1 N LEU A 373 O ALA A 389 SHEET 1 AA2 5 ILE A 350 SER A 353 0 SHEET 2 AA2 5 VAL A 401 MET A 407 1 O GLN A 405 N LEU A 352 SHEET 3 AA2 5 THR A 511 ARG A 520 -1 O TYR A 514 N LEU A 406 SHEET 4 AA2 5 ASN A 447 SER A 457 -1 N HIS A 451 O VAL A 517 SHEET 5 AA2 5 GLN A 430 PRO A 432 -1 N LEU A 431 O TYR A 448 SHEET 1 AA3 7 ILE A 350 SER A 353 0 SHEET 2 AA3 7 VAL A 401 MET A 407 1 O GLN A 405 N LEU A 352 SHEET 3 AA3 7 THR A 511 ARG A 520 -1 O TYR A 514 N LEU A 406 SHEET 4 AA3 7 ASN A 447 SER A 457 -1 N HIS A 451 O VAL A 517 SHEET 5 AA3 7 HIS A 464 LEU A 469 -1 O VAL A 466 N VAL A 455 SHEET 6 AA3 7 TRP A 477 ASP A 481 -1 O PHE A 480 N VAL A 467 SHEET 7 AA3 7 VAL A 484 CYS A 488 -1 O SER A 486 N LYS A 479 SHEET 1 AA4 2 TYR A 379 ASP A 380 0 SHEET 2 AA4 2 LEU A 386 GLN A 387 -1 O GLN A 387 N TYR A 379 SHEET 1 AA5 2 PHE A 409 MET A 410 0 SHEET 2 AA5 2 ILE A 419 LYS A 420 -1 N ILE A 419 O MET A 410 SHEET 1 AA6 4 ARG B 340 TYR B 347 0 SHEET 2 AA6 4 GLY B 326 CYS B 334 -1 N MET B 328 O GLU B 345 SHEET 3 AA6 4 ALA B 389 THR B 397 -1 O LYS B 394 N VAL B 329 SHEET 4 AA6 4 GLU B 371 LEU B 373 -1 N LEU B 373 O ALA B 389 SHEET 1 AA7 5 ILE B 350 SER B 353 0 SHEET 2 AA7 5 VAL B 401 MET B 407 1 O GLN B 405 N LEU B 352 SHEET 3 AA7 5 THR B 511 ARG B 520 -1 O TYR B 514 N LEU B 406 SHEET 4 AA7 5 ASN B 447 SER B 457 -1 N HIS B 451 O VAL B 517 SHEET 5 AA7 5 GLN B 430 PRO B 432 -1 N LEU B 431 O TYR B 448 SHEET 1 AA8 7 ILE B 350 SER B 353 0 SHEET 2 AA8 7 VAL B 401 MET B 407 1 O GLN B 405 N LEU B 352 SHEET 3 AA8 7 THR B 511 ARG B 520 -1 O TYR B 514 N LEU B 406 SHEET 4 AA8 7 ASN B 447 SER B 457 -1 N HIS B 451 O VAL B 517 SHEET 5 AA8 7 HIS B 464 LEU B 469 -1 O HIS B 464 N SER B 457 SHEET 6 AA8 7 TRP B 477 ASP B 481 -1 O PHE B 480 N VAL B 467 SHEET 7 AA8 7 VAL B 484 CYS B 488 -1 O SER B 486 N LYS B 479 SHEET 1 AA9 2 TYR B 379 ASP B 380 0 SHEET 2 AA9 2 LEU B 386 GLN B 387 -1 O GLN B 387 N TYR B 379 SHEET 1 AB1 2 PHE B 409 TYR B 411 0 SHEET 2 AB1 2 ASN B 418 LYS B 420 -1 O ILE B 419 N MET B 410 SITE 1 AC1 16 ASP A 295 VAL A 296 GLN A 297 GLN A 351 SITE 2 AC1 16 LEU A 406 MET A 407 ARG A 408 PHE A 409 SITE 3 AC1 16 ASN A 418 LYS A 420 ASP A 459 ASN A 460 SITE 4 AC1 16 HIS A 461 TYR A 465 TYR A 514 HOH A 717 SITE 1 AC2 17 ASP B 295 VAL B 296 GLN B 297 GLN B 351 SITE 2 AC2 17 LEU B 406 MET B 407 ARG B 408 PHE B 409 SITE 3 AC2 17 ASN B 418 LYS B 420 ASP B 459 ASN B 460 SITE 4 AC2 17 HIS B 461 TYR B 465 TYR B 514 HOH B 729 SITE 5 AC2 17 HOH B 735 CRYST1 76.065 69.200 76.450 90.00 95.56 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013147 0.000000 0.001281 0.00000 SCALE2 0.000000 0.014451 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013142 0.00000